These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 1703788
1. Acidic residues at the carboxyl terminus of p60c-src are required for regulation of tyrosine kinase activity and transformation. MacAuley A, Cooper JA. New Biol; 1990 Sep; 2(9):828-40. PubMed ID: 1703788 [Abstract] [Full Text] [Related]
2. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src. Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H. Nature; 1991 May 02; 351(6321):69-72. PubMed ID: 1709258 [Abstract] [Full Text] [Related]
3. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants. Jove R, Hanafusa T, Hamaguchi M, Hanafusa H. Oncogene Res; 1989 May 02; 5(1):49-60. PubMed ID: 2476707 [Abstract] [Full Text] [Related]
4. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK. MacAuley A, Okada M, Nada S, Nakagawa H, Cooper JA. Oncogene; 1993 Jan 02; 8(1):117-24. PubMed ID: 7678701 [Abstract] [Full Text] [Related]
5. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation. Espino PC, Harvey R, Schweickhardt RL, White GA, Smith AE, Cheng SH. Oncogene; 1990 Mar 02; 5(3):283-93. PubMed ID: 1690377 [Abstract] [Full Text] [Related]
6. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527. Cobb BS, Parsons JT. Oncogene; 1993 Nov 02; 8(11):2897-903. PubMed ID: 7692368 [Abstract] [Full Text] [Related]
7. Properties of tripartite chimeras between Src and Lck. Kashishian A, MacAuley A, Cooper JA. Oncogene; 1990 Oct 02; 5(10):1463-70. PubMed ID: 2250908 [Abstract] [Full Text] [Related]
8. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain. Liu X, Brodeur SR, Gish G, Songyang Z, Cantley LC, Laudano AP, Pawson T. Oncogene; 1993 May 02; 8(5):1119-26. PubMed ID: 7683128 [Abstract] [Full Text] [Related]
9. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells. Kamps MP, Sefton BM. Oncogene Res; 1988 Sep 02; 3(2):105-15. PubMed ID: 2465525 [Abstract] [Full Text] [Related]
10. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95. Potts WM, Reynolds AB, Lansing TJ, Parsons JT. Oncogene Res; 1988 Sep 02; 3(4):343-55. PubMed ID: 2465527 [Abstract] [Full Text] [Related]
12. The role of autophosphorylation in modulation of erbB-2 transforming function. Segatto O, Lonardo F, Pierce JH, Bottaro DP, Di Fiore PP. New Biol; 1990 Feb 02; 2(2):187-95. PubMed ID: 1982072 [Abstract] [Full Text] [Related]
13. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line. Lansing TJ, Turk BF, Kanner SB, Gilmer TM. Cancer Res; 1997 May 15; 57(10):1962-9. PubMed ID: 9157992 [Abstract] [Full Text] [Related]
15. Association of p60c-src with polyoma virus middle-T antigen abrogating mitosis-specific activation. Kaech S, Covic L, Wyss A, Ballmer-Hofer K. Nature; 1991 Apr 04; 350(6317):431-3. PubMed ID: 1707141 [Abstract] [Full Text] [Related]
16. Altered tyrosine 527 phosphorylation and mitotic activation of p60c-src. Bagrodia S, Chackalaparampil I, Kmiecik TE, Shalloway D. Nature; 1991 Jan 10; 349(6305):172-5. PubMed ID: 1702522 [Abstract] [Full Text] [Related]
17. Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Zheng XM, Wang Y, Pallen CJ. Nature; 1992 Sep 24; 359(6393):336-9. PubMed ID: 1383828 [Abstract] [Full Text] [Related]
18. Function, location, and regulation of the src protein-tyrosine kinase. Varmus H, Hirai H, Morgan D, Kaplan J, Bishop JM. Princess Takamatsu Symp; 1989 Sep 24; 20():63-70. PubMed ID: 2484925 [Abstract] [Full Text] [Related]
19. Phosphorylation and regulatory effects of the carboxy terminus of a Drosophila src homolog. Kussick SJ, Cooper JA. Oncogene; 1992 Aug 24; 7(8):1577-86. PubMed ID: 1630818 [Abstract] [Full Text] [Related]
20. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav. Katzav S. Oncogene; 1993 Jul 24; 8(7):1757-63. PubMed ID: 8510922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]